Publications by authors named "Annette Walter"

Claim this Profile
A
Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks.
Carolin Schwake, Theodoros Ladopoulos, Vivien Häußler, Ingo Kleiter, Marius Ringelstein, Annette Walter

J Neurol Neurosurg Psychiatry· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD.
Vivien Häußler, Corinna Trebst, Daniel Engels, Hanna Pellkofer, Joachim Havla, Annette Walter

J Neurol Neurosurg Psychiatry· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Worse recovery from acute attacks and faster disability accumulation highlights the unmet need for improved treatment in patients with late-onset neuromyelitis optica spectrum disorders (COPTER-LO study).
Julian Reza Kretschmer, Daria Tkachenko, Tania Kümpfel, Joachim Havla, Daniel Engels, Annette Walter

Front Immunol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognition in patients with myelin oligodendrocyte glycoprotein antibody-associated disease: a prospective, longitudinal, multicentre study of 113 patients (CogniMOG-Study).
Sarah Passoke, Carlotta Stern, Vivien Häußler, Tania Kümpfel, Joachim Havla, Annette Walter

J Neurol Neurosurg Psychiatry· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and vision.
Mihaela Nicolescu, Vivien Häußler, Friedemann Paul, Frederike Cosima Oertel, Patrick Schindler, Annette Walter

J Neurol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling.
Keith Graham, Philip Lienau, Benjamin Bader, Stefan Prechtl, Jan Naujoks, Annette O Walter

Cell Chem Biol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to Disability Milestones and Annualized Relapse Rates in NMOSD and MOGAD.
Ankelien Duchow, Judith Bellmann-Strobl, Tim Friede, Orhan Aktas, Klemens Angstwurm, Annette Walter

Ann Neurol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study).
Martin W Hümmert, Carlotta Stern, Friedemann Paul, Ankelien Duchow, Judith Bellmann-Strobl, Annette Walter

Mult Scler· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and activity of anti-mesothelin antibody-drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose escalation and expansion study.
Alessandro D Santin, Ignace Vergote, Antonio González-Martín, Kathleen Moore, Ana Oaknin, Annette O Walter

Int J Gynecol Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Diseases: COPANMO(G)-Study.
Martin W Hümmert, Franziska Bütow, Daria Tkachenko, Ilya Ayzenberg, Thivya Pakeerathan, Annette Walter

Neurol Neuroimmunol Neuroinflamm· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial.
Hedy L Kindler, Silvia Novello, Alessandra Bearz, Giovanni L Ceresoli, Joachim G J V Aerts, Annette O Walter

Lancet Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Disease: CHANCE Study.
Martin W Hümmert, Louisa M Schöppe, Judith Bellmann-Strobl, Nadja Siebert, Friedemann Paul, Annette Walter

Neurology· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis of patients with malignant mesothelioma by expression of programmed cell death 1 ligand 1 and mesothelin in a contemporary cohort in Finland.
David Vizcaya, Bahman Farahmand, Annette O Walter, Christoph Kneip, Korinna Jöhrens

Cancer Treat Res Commun· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD20 therapies and pregnancy in neuroimmunologic disorders: A cohort study from Germany.
Tania Kümpfel, Sandra Thiel, Ingrid Meinl, Andrea I Ciplea, Antonios Bayas, Annette Walter

Neurol Neuroimmunol Neuroinflamm· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody-Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors.
Raffit Hassan, George R Blumenschein, Kathleen N Moore, Alessandro D Santin, Hedy L Kindler, Annette O Walter

J Clin Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human phase I study of the bromodomain and extraterminal motif inhibitor BAY 1238097: emerging pharmacokinetic/pharmacodynamic relationship and early termination due to unexpected toxicity.
Sophie Postel-Vinay, Karin Herbschleb, Christophe Massard, Victoria Woodcock, Jean-Charles Soria, Annette O Walter

Eur J Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma.
Clemens Krepler, Katrin Sproesser, Patricia Brafford, Marilda Beqiri, Bradley Garman, Annette Walter

Cell Rep· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I dose-escalation studies of roniciclib, a pan-cyclin-dependent kinase inhibitor, in advanced malignancies.
Rastislav Bahleda, Juneko E Grilley-Olson, Ramaswamy Govindan, Fabrice Barlesi, Laurent Greillier, Annette O Walter

Br J Cancer· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visualizing the surface of a living human brain.
Llyr ap Cenydd, Nigel John, Marina Bloj, Annette Walter, Nicholas I Phillips

IEEE Comput Graph Appl· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo characterization of irreversible mutant-selective EGFR inhibitors that are wild-type sparing.
Robert Tjin Tham Sjin, Kwangho Lee, Annette O Walter, Aleksandr Dubrovskiy, Michael Sheets

Mol Cancer Ther· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC.
Annette O Walter, Robert Tjin Tham Sjin, Henry J Haringsma, Kadoaki Ohashi, Jing Sun

Cancer Discov· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3D Pharmacophore Model-Assisted Discovery of Novel CDC7 Inhibitors.
Mika Lindvall, Christopher McBride, Maureen McKenna, Thomas G Gesner, Asha Yabannavar, Annette Walter

ACS Med Chem Lett· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Realistic visualization of living brain tissue.
Llyr ap Cenydd, Annette Walter, Nigel W John, Marina Bloj, Nicholas Phillips

Stud Health Technol Inform· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous examination of tear film break-up and the lipid layer of the human eye: a novel sensor design (Part 1).
Stefan Arnold, Annette Walter, Timo Eppig, Holger Bruenner, Achim Langenbucher

Z Med Phys· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of tetrahydro-beta-carbolines as inhibitors of the kinesin Eg5.
Paul A Barsanti, Weibo Wang, Zhi-Jie Ni, David Duhl, Nathan Brammeier, Annette O Walter

Bioorg Med Chem Lett· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis